Dr. Harsha Rajasimha has over 15 years of experience and widely recognized in the field of systems biology, Genomics BigData analytics, rare diseases and precision medicine for cancer. Dr. Rajasimha is co-founder and board member of the non-profit organization for rare diseases India (www.ordindia.org) and established mechanisms to accelerate rare disease diagnosis, public health policies and accessibility of treatments for patients in India. He is currently global head of life sciences R&D IT solutions for Dell and co-directs the center for metabolic and rare diseases at George Mason University. Before this, he led the global strategy and business development for Strand Life Sciences, a CAP/CLIA laboratory and Bioinformatics powerhouse for precision medicine.
An entrepreneur, Dr. Rajasimha founded Jeeva Informatics Solutions in 2013, a life sciences BigData Informatics company that received the ‘Bioscience Company of the Year 2014’ award from Montgomery County, MD. Dr. Rajasimha has led the development of some of the largest genomics projects including PathogenPortal, Pathosystems resource integration center, Cancer Biomedical Informatics Grid (caBIG), LIMS implementation at the FDA Office of Regulatory Affairs, architected Genome Explorer® a web-based platform for next-generation sequencing (NGS) data analysis for Genome International Corporation and Cyberinfrastructure development for National Eye Institute’s genomics program. His contributions to the NGS program were recognized by NEI director’s innovation award in 2012.
An accomplished scientist, Dr. Rajasimha has authored over 15 peer-reviewed articles, book chapters, and is often invited speaker at international conferences. He has contributed to global standards initiatives such as BioPAX, DELSAGlobal, personalized medicine coalition, and the global alliance for genomics and health. He earned baccalaureate degree in computer science engineering from Bangalore University, Masters in Computer Science & Bioinformatics and Doctoral degree in interdisciplinary program genetics, bioinformatics and computational biology from Virginia Tech.
World Orphan Drug Congress USA 2018 – Seminars @ 16:20
Integrating structured and unstructured data and digital health technologies to accelerate biopharma R&D
World Orphan Drug Congress USA 2018 – Conference Day One @ 11:50
INDIA Rising in Healthcare and Rare Diseases
Visit the conference website for more details.